{
    "0239.HK": {
        "short_name": "PAK FAH YEOW",
        "long_name": "Pak Fah Yeow International Limited",
        "summary": "Pak Fah Yeow International Limited, an investment holding company, together with its subsidiaries, manufactures, markets, and distributes healthcare products under the Hoe Hin brand name in the People's Republic of China, Hong Kong, Macau, Southeast Asia, North America, the United Kingdom, and internationally. It operates through three segments: Healthcare, Property Investments, and Treasury Investments. The company offers white flower embrocation medicated oils, strain relief products, and ointments under the under the Hoe Hin brand name, as well as F\u00c3\u00bazai 239, a floral-scented white flower embrocation. In addition, it invests in commercial, industrial, residential, and car park properties; and provides advertising agency services. The company was founded in 1927 and is headquartered in Wan Chai, Hong Kong.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "Hong Kong",
        "state": null,
        "city": "Wan Chai",
        "zipcode": null,
        "website": "http://www.pakfahyeow.com",
        "market_cap": "Micro Cap"
    },
    "0455.HK": {
        "short_name": "TIANDA PHARMA",
        "long_name": "Tianda Pharmaceuticals Limited",
        "summary": "Tianda Pharmaceuticals Limited, an investment holding company, engages in the research and development, production, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. Its product range includes Chinese and western medicines and biochemical drugs, etc., such as cardio-cerebrovascular drugs, pediatric drugs, anti-flu and respiratory system drugs, anti-infection drugs, detoxification agents, and other pharmaceutical products. The company offers its health care products under the Herb Valley brand name. It also engages in the sale and wholesale of Chinese herbal medicines, traditional Chinese medicine decoction pieces and Chinese medicines; property holding business; provision of Chinese medical services; and trading of agricultural by-products. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. The company is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "Hong Kong",
        "state": null,
        "city": "Central",
        "zipcode": null,
        "website": "http://www.tiandapharma.com",
        "market_cap": "Micro Cap"
    },
    "0460.HK": {
        "short_name": "SIHUAN PHARM",
        "long_name": "Sihuan Pharmaceutical Holdings Group Ltd.",
        "summary": "Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China. The company offers cardio-cerebral vascular system, digestive system, metabolism, anti-infective, respiratory, neurology, and other drugs. It also engages in the marketing of pharmaceutical products; manufacture of pharmaceutical materials and medical instruments; project preparation for the manufacture of pharmaceutical products; promotion of technology, biotechnology, and consulting services; and construction of medical projects, as well as the provision of information support, research and development, business and development, and general hospital and hospital management services. In addition, the company invests in property; constructs environmental protection projects; and wholesales chemical raw materials and medical devices. The company was founded in 2001 and is based in Wanchai, Hong Kong.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "Hong Kong",
        "state": null,
        "city": "Wan Chai",
        "zipcode": null,
        "website": "http://www.sihuanpharm.com",
        "market_cap": "Mid Cap"
    },
    "0858.HK": {
        "short_name": "EXTRAWELL PHAR",
        "long_name": "Extrawell Pharmaceutical Holdings Limited",
        "summary": "Extrawell Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, and sells pharmaceutical products in the People's Republic of China. It operates through Manufacturing, Trading, and Gene Development segments. The company offers transfer factor oral solution, a dual immune regulator for the treatment of diseases caused by virus infection and weak cellular immune system; and Wisk for the treatment of II-III degree of radio-injury of skin, normal common burn, actinic dermatitis, various infectious ulcers, and oral ulcers, as well as for trauma and post operation wound healing. It also provides ZhouBang, a thromboxane synthetase inhibitor to prevent the coagulation of platelets and facilitate relaxation of blood vessels. In addition, the company is involved in the marketing and distribution of imported pharmaceutical products, including GM-1 to treat lesions of central nervous system caused due to vascular or traumatic events, and Parkinson's disease; Millibar for the treatment of high blood pressure; and Skin-Cap for use in the treatment of psoriasis, dandruff, dermatitis, atopic dermatitis, eczema, and tinea. Further, it engages in the commercial exploitation and development of genome-related technology; provision of agency services; property investment business; and holds gene invention rights. The company is headquartered in Quarry Bay, Hong Kong.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "Hong Kong",
        "state": null,
        "city": "Quarry Bay",
        "zipcode": null,
        "website": "http://www.extrawell.com.hk",
        "market_cap": "Nano Cap"
    },
    "0897.HK": {
        "short_name": "WAI YUEN TONG",
        "long_name": "Wai Yuen Tong Medicine Holdings Limited",
        "summary": "Wai Yuen Tong Medicine Holdings Limited, an investment holding company, manufactures, processes, and retails traditional Chinese medicine, western pharmaceutical products, and health food and personal products in Hong Kong, Mainland China, Macau, and internationally. The company offers Chinese medicines and health food products under the Wai Yuen Tong brand name; and western pharmaceutical and personal care products under the Madame Pearl's and Pearl's brands. It also engages in the investment, holding, and selling of properties; provision of financial services; and agricultural produce exchange market operation. It operates approximately 55 retail stores in Hong Kong. The company was founded in 1897 and is headquartered in Kowloon Bay, Hong Kong. Wai Yuen Tong Medicine Holdings Limited is a subsidiary of Rich Time Strategy Limited.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "Hong Kong",
        "state": null,
        "city": "Kowloon Bay",
        "zipcode": null,
        "website": "http://www.wyth.net",
        "market_cap": "Micro Cap"
    },
    "0911.HK": {
        "short_name": "QIANHAI HEALTH",
        "long_name": "Qianhai Health Holdings Limited",
        "summary": "Qianhai Health Holdings Limited, an investment holding company, engages in the sale of health products in Hong Kong. It operates through Health-Care Products and Electronic Component Products segments. The company offers Chinese herbal medicines, and skin-care and other health-care products to wholesalers and retailers. It offers American ginseng, an herbaceous perennial plant, which includes cultivated and wild ginseng; and ginseng wine. The company is also involved in the sale of information technology components, such as central processing units and semi-conductors. In addition, it engages in the property and other assets holding, and property leasing activities; and money lending business through the provision of secured and unsecured loans. The company was formerly known as Hang Fat Ginseng Holdings Company Limited and changed its name to Qianhai Health Holdings Limited in September 2016. The company was founded in 1989 and is based in Sheung Wan, Hong Kong. Qianhai Health Holdings Limited is a subsidiary of Explorer Rosy Limited.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "Hong Kong",
        "state": null,
        "city": "Sheung Wan",
        "zipcode": null,
        "website": "http://www.qianhaihealth.com.hk",
        "market_cap": "Nano Cap"
    },
    "1498.HK": {
        "short_name": "PURAPHARM",
        "long_name": "PuraPharm Corporation Limited",
        "summary": "PuraPharm Corporation Limited, an investment holding company, researches, develops, produces, and sells concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mailand China, and internationally. The company operates through five segments: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. It offers holistic products under the PuraGold, Haveron, CardioClear, PuraPharm Lingzhi, and Arashi Kuni names; and various therapeutic products under the Nong's, Oncozac, and Immuzac names for Chinese medicine practitioners. It also provides Chinese medicine clinic management system for general clinic management; and operates Chinese medicine clinics under the Nong's name that provide Chinese medicine services and concentrated Chinese medicine granules (CCMG) products. In addition, the company engages in the plantation and trading of raw Chinese herbs; and manufacture and sale of traditional Chinese medicine decoction pieces. Further, it researches, develops, and trades in modernized Chinese medicines; and provides Chinese medical diagnostic services. The company sells its products to hospitals, medical institutions, and medicine practitioners, as well as operates an online store. As of December 31, 2019, the company operated 67 Nong's clinics in Hong Kong and 1 Nong's clinic in Guangxi, China. The company was founded in 1998 and is headquartered in Central, Hong Kong.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "Hong Kong",
        "state": null,
        "city": "Central",
        "zipcode": null,
        "website": "http://www.purapharm.com",
        "market_cap": "Nano Cap"
    },
    "2005.HK": {
        "short_name": "SSY GROUP",
        "long_name": "SSY Group Limited",
        "summary": "SSY Group Limited, an investment holding company, researches, develops, manufactures, and sells various pharmaceutical products to hospitals and distributors in the People's Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC soft bags, upright soft bags, PP plastic bottles, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials. In addition, the company is involved in the research, development, and consulting of pharmaceutical technology; provision of logistics services for pharmaceutical products; and food, beverages, and catering business. It sells its products under Shimen brand name. The company was formerly known as Lijun International Pharmaceutical (Holding) Co., Ltd. and changed its name to SSY Group Limited in May 2015. The company was incorporated in 2004 and is headquartered in Wanchai, Hong Kong. SSY Group Limited is a subsidiary of China Pharmaceutical Co., Ltd.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "Hong Kong",
        "state": null,
        "city": "Wan Chai",
        "zipcode": null,
        "website": "http://www.ssygroup.com.hk",
        "market_cap": "Mid Cap"
    },
    "2348.HK": {
        "short_name": "DAWNRAYS PHARMA",
        "long_name": "Dawnrays Pharmaceutical (Holdings) Limited",
        "summary": "Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. The company operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. It offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics; and system specific medicines for various therapeutic areas comprising cardiovascular system, anti-allergic, anti-HBV, digestive system, urinary system, anti-pyretic analgesic, respiratory, and endocrine system drugs in the form of tablets, capsules, and granules. The company was founded in 1995 and is headquartered in Wanchai, Hong Kong. Dawnrays Pharmaceutical (Holdings) Limited is a subsidiary of Fortune United Group Limited.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "Hong Kong",
        "state": null,
        "city": "Wan Chai",
        "zipcode": null,
        "website": "http://www.dawnrays.com",
        "market_cap": "Small Cap"
    },
    "2633.HK": {
        "short_name": "JACOBSON PHARMA",
        "long_name": "Jacobson Pharma Corporation Limited",
        "summary": "Jacobson Pharma Corporation Limited, through its subsidiaries, manufactures and trades in generic drugs and proprietary medicines in Hong Kong, China, Macau, Singapore, and internationally. The company offers generic drugs for various therapeutic categories, including respiratory, cardiovascular, central nervous system, gastrointestinal, scar treatment, and oral anti-diabetics, anti-infective, diltiazem controlled release, dihydrocodeine, perindopril tablets. propranolol oral solution, mesalazine enteric coated tablets 500mg and finasteride tablets dermatological, and anti-allergic drugs. It also provides proprietary Chinese medicines, such as Po Chai pills, Ho Chai Kung Tji Thung San, Tong Tai Chung Woodlok oil, Flying Eagle Woodlok Oil, Saplingtan/Shiling oil, and Col-gan tablet. In addition, it trades in medical supplies. Jacobson Pharma Corporation Limited sells its products to hospitals and clinics, and registered pharmacies, as well as to doctors in private and retail outlets, and trading companies. The company was incorporated and is headquartered in Kwun Tong, Hong Kong. Jacobson Pharma Corporation Limited is a subsidiary of Kingshill Development Limited.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "Hong Kong",
        "state": null,
        "city": "Kwun Tong",
        "zipcode": null,
        "website": "http://www.jacobsonpharma.com",
        "market_cap": "Micro Cap"
    },
    "8622.HK": {
        "short_name": "HUAKANG BIOMED",
        "long_name": "Huakang Biomedical Holdings Company Limited",
        "summary": "Huakang Biomedical Holdings Company Limited, a medical device company, engages in the research, development, manufacture, marketing, and sale of in-vitro diagnostic (IVD) reagents in the People's Republic of China. It offers male and female fertility IVD, parasite antibody detection, and Epstein-Barr virus antibody detection reagents; and auxiliary reproductive supplies and equipment. The company sells its products directly to hospitals and medical institutions, as well as to distributors. Huakang Biomedical Holdings Company Limited was founded in 1992 and is headquartered in Wan Chai, Hong Kong.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "Hong Kong",
        "state": null,
        "city": "Wan Chai",
        "zipcode": null,
        "website": "http://www.huakangbiomedical.com",
        "market_cap": "Nano Cap"
    },
    "SKYI": {
        "short_name": "SKY CENTURY INVESTMENT INC",
        "long_name": "Sky Century Investment, Inc.",
        "summary": "Sky Century Investment, Inc., a development stage company, intends to find and manage new music talents and bands in China. The company was formerly known as Band Rep Management, Inc. and changed its name to Sky Century Investment, Inc. in May 2017. The company was founded in 2012 and is based in Tsim Sha Tsui, Hong Kong.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Hong Kong",
        "state": null,
        "city": "Tsim Sha Tsui",
        "zipcode": null,
        "website": "http://skycenturygroup.com",
        "market_cap": "Small Cap"
    },
    "TEL1.F": {
        "short_name": "SIHUAN PHARMAC.GRP HD-,01",
        "long_name": "Sihuan Pharmaceutical Holdings Group Ltd.",
        "summary": "Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China. The company offers cardio-cerebral vascular system, digestive system, metabolism, anti-infective, respiratory, neurology, and other drugs. It also engages in the marketing of pharmaceutical products; manufacture of pharmaceutical materials and medical instruments; project preparation for the manufacture of pharmaceutical products; promotion of technology, biotechnology, and consulting services; and construction of medical projects, as well as the provision of information support, research and development, business and development, and general hospital and hospital management services. In addition, the company invests in property; constructs environmental protection projects; and wholesales chemical raw materials and medical devices. The company was founded in 2001 and is based in Wanchai, Hong Kong.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Hong Kong",
        "state": null,
        "city": "Wan Chai",
        "zipcode": null,
        "website": "http://www.sihuanpharm.com",
        "market_cap": "Mid Cap"
    }
}